Seattle Genetics reported $3.11B in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Acadia Pharmaceuticals ACAD:US $ 640.92M 4.81M
Agios Pharmaceuticals AGIO:US $ 1305.29M 397.28M
Alexion Pharmaceuticals ALXN:US $ 6452.6M 619.6M
Amgen AMGN:US $ 24380M 5281M
Astellas Pharma 4503:JP Y 876454M 7739M
Bayer BAYN:GR 31.94B 506M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Bluebird Bio BLUE:US $ 832.32M 71.2M
Bristol Myers Squibb BMY:US $ 31443M 2282M
Celldex Therapeutics CLDX:US $ 426.56M 258.95M
Clovis Oncology CLVS:US $ 230.67M 65.69M
Daiichi Sankyo 4568:JP Y 1270181M 36484M
Eisai 4523:JP Y 570717M 8210M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Esperion Therapeutics ESPR:US $ 170.67M 104.51M
Exelixis EXEL:US $ 1662.03M 68.78M
Genmab GEN:DC 21.95B 1.65B
Gilead Sciences GILD:US $ 14200M 275M
Glaxosmithkline GSK:US $ 18254M 688M
GlaxoSmithKline GSK:LN 18.25B 688M
Immunogen IMGN:US $ 296.8M 22.41M
Insmed INSM:US $ 958.98M 79.21M
Karyopharm Therapeutics KPTI:US $ 241.58M 31.92M
Macrogenics MGNX:US $ 334.7M 32.3M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Moderna Inc MRNA:US 13.42B 2.46B
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Novartis NOVN:VX 26.25B 2.45B
Puma Biotechnology PBYI:US $ 136.92M 30.83M
Regeneron Pharmaceuticals REGN:US $ 13775.4M 437.8M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Spectrum Pharmaceuticals SPPI:US $ 140M 25.71M
Takeda 4502:JP Y 2456353M 20105M
Teva Pharmaceutical TEVA:IT 12.15B 668M
Vertex Pharmaceuticals VRTX:US $ 8852.54M 395.03M
Xencor XNCR:US $ 329.63M 151.34M
YTE INCY:US $ 2923.8M 303.74M